Merck dumps VIOXX | Merck makes a STUNNING announcement this morning: The voluntary withdrawal of VIOXX from its WORLDWIDE market. In opening trading on the NYSE, Merck, a DOW component, is trading down about $12.00 | The drugmaker says a study evaluating the efficacy of Vioxx in preventing recurrence of colorectal polyps showed an increased risk for confirmed cardiovascular events |
Some history, appearing to be contradictory:
• 08 sep 04 FDA Approves VIOXX for child arthritis [The Street.com]
• 26 aug 04 Merck faces challenges from lawsuits [Forbes]
• 26 aug 04 VIOXX suffers a setback [Business Week]
posted by Will Brady @ 10:34
0 Comments:
Post a Comment
<< Home